Znn3bq.jpeg
²é¿´: 256  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

lihongbo9079

ľ³æ (СÓÐÃûÆø)

[½»Á÷] ¡¾ÒÑËÑË÷£¬ÎÞÖØ¸´¡¿¿Æ¼¼ÂÛÎÄÓ¢ÎÄÕªÒªµÄ׫д

0  ÒýÑÔ
    ÕªÒªµÄ¶¨ÒåΪ£º ¡° ÒÔÌṩÎÄÏ×ÄÚÈݹ£¸ÅΪĿµÄ , ²»¼ÓÆÀÂۺͲ¹³ä½âÊÍ , ¼òÃ÷¡¢È·ÇеؼÇÐðÎÄÏ×ÖØÒªÄÚÈݵĶÌÎÄ ¡± ¡£ÓÉÓÚ´ó¶àÊý¼ìË÷ϵͳֻÊÕ¼ÂÛÎĵÄÕªÒª²¿·Ö£¬»òÆäÊý¾Ý¿âÖÐÖ»ÓÐÕªÒª²¿·ÖÃâ·ÑÌṩ , ²¢ÇÒÓÐЩ¶ÁÕßÖ»ÔĶÁÕªÒª¶ø²»¶ÁÈ«ÎÄ»ò³£¸ù¾ÝÕªÒªÀ´ÅжÏÊÇ·ñÐèÒªÔĶÁÈ«ÎÄ , Òò´ËÕªÒªµÄÇå³þ±í´ïÊ®·ÖÖØÒª¡£ºÃµÄÓ¢ÎÄÕªÒª¶ÔÓÚÔö¼ÓÂÛÎĵı»¼ìË÷ºÍÒýÓûú»á¡¢ÎüÒý¶ÁÕß¡¢À©´óÓ°ÏìÆð×Ų»¿ÉºöÊÓµÄ×÷Óá£

1 ÕªÒªµÄÀàÐÍÓë»ù±¾ÄÚÈÝ
  1.1 ÕªÒªµÄÀàÐÍ   

    ¸ù¾ÝÄÚÈݵIJ»Í¬ , ÕªÒª¿É·ÖΪÒÔÏÂÈý´óÀࣺ±¨µÀÐÔÕªÒª¡¢Ö¸Ê¾ÐÔÕªÒªºÍ±¨µÀ - ָʾÐÔÕªÒª¡£

£¨ 1 £©±¨µÀÐÔÕªÒª (informative abstract) £ºÒ²³ÆÐÅÏ¢ÐÍÕªÒª»ò×ÊÁÏÐÔÕªÒª¡£ÆäÌØµãÊÇÈ«Ãæ¡¢¼òÒªµØ¸ÅÀ¨ÂÛÎĵÄÄ¿µÄ¡¢·½·¨¡¢Ö÷ÒªÊý¾ÝºÍ½áÂÛ¡£Í¨³£ , ÕâÖÖÕªÒª¿É²¿·ÖµØÈ¡´úÔĶÁÈ«ÎÄ¡£

£¨ 2 £©Ö¸Ê¾ÐÔÕªÒª (indicative abstract) £ºÒ²³ÆÎªËµÃ÷ÐÔÕªÒª¡¢ÃèÊöÐÔÕªÒª£¨ descriptive abstract £©»òÂÛµãÕªÒª£¨ topic abstract £©¡£Ò»°ãÖ»Óöþ¡¢Èý¾ä»°¸ÅÀ¨ÂÛÎĵÄÖ÷Ìâ , ¶ø²»Éæ¼°Â۾ݺͽáÂÛ , ¶àÓÃÓÚ×ÛÊö¡¢»áÒ鱨¸æµÈ¡£´ËÀàÕªÒª¿ÉÓÃÓÚ°ïÖú¶ÁÕß¾ö¶¨ÊÇ·ñÐèÒªÔĶÁÈ«ÎÄ¡£

£¨ 3 £©±¨µÀ - ָʾÐÔÕªÒª (informative-indicative abstract) £ºÒÔ±¨µÀÐÔÕªÒªµÄÐÎʽ±íÊöÒ»´ÎÎÄÏ×ÖÐÐÅÏ¢¼ÛÖµ½Ï¸ßµÄ²¿·Ö , ÒÔָʾÐÔÕªÒªµÄÐÎʽ±íÊöÆäÓಿ·Ö¡£
´«Í³µÄÕªÒª¶àΪһ¶Îʽ , ÔÚÄÚÈÝÉÏ´óÖ°üÀ¨ÒýÑÔ (Introduction) ¡¢²ÄÁÏÓë·½·¨ (Materials and Methods) ¡¢½á¹û (Results) ºÍÌÖÂÛ (Discussion) µÈÖ÷Òª·½Ãæ , ¼´ IMRAD £¨ Introduction,  Methods,  Results and Discussion £©½á¹¹µÄд×÷ģʽ¡£
1980 Äê´ú³öÏÖÁËÁíÒ»ÖÖÕªÒªÎÄÌå , ¼´ ¡° ½á¹¹Ê½ÕªÒª ¡±(structured abstract), ËüÊDZ¨µÀÐÔÕªÒªµÄ½á¹¹»¯±í´ï£¬Ç¿µ÷ÂÛÎÄÕªÒªÓ¦º¬Óн϶àµÄÐÅÏ¢Á¿¡£½á¹¹Ê½ÕªÒªÓ봫ͳժҪµÄ²î±ðÔÚÓÚ£¬Ç°Õß±ãÓÚ¶ÁÕßÁ˽âÂÛÎĵÄÄÚÈÝ , ÐÐÎÄÖÐÓÃÐÑÄ¿µÄ×ÖÌ壨ºÚÌ塢ȫ²¿´óд»òбÌåµÈ£©Ö±½Ó±ê³öÄ¿µÄ¡¢·½·¨¡¢½á¹ûºÍ½áÂ۵ȱêÌâ¡£
1. 2 ÕªÒªµÄ»ù±¾½á¹¹ºÍÄÚÈÝ

    ÕªÒª±¾ÖÊÉÏÊÇһƪ¸ß¶ÈŨËõµÄÂÛÎÄ , ËùÒÔÆä¹¹³ÉÓëÂÛÎÄÖ÷ÌåµÄ IMRAD ½á¹¹ÊǶÔÓ¦µÄ¡£ÕªÒªÓ¦°üÀ¨ÒÔÏÂÄÚÈݹ£¸Å£º£¨ 1 £©Ä¿µÄ£ºÑо¿¹¤×÷µÄǰÌᡢĿµÄºÍÈÎÎñ , ËùÉæ¼°µÄÖ÷ÌⷶΧ£»£¨ 2 £©·½·¨£ºËùÓõÄÀíÂÛ¡¢Ìõ¼þ¡¢²ÄÁÏ¡¢ÊֶΡ¢×°±¸¡¢³ÌÐòµÈ£»£¨ 3 £©½á¹û£º¹Û²ì¡¢ÊµÑéµÄ½á¹û¡¢ Êý¾Ý¡¢ÐÔÄܵȣ»£¨ 4 £©½á¹ûµÄ·ÖÎö¡¢±È½Ï¡¢ÆÀ¼Û¡¢Ó¦Óà , Ìá³öµÄÎÊÌâ , ½ñºóµÄ¿ÎÌâ , ¼ÙÉè¡¢Æô·¢¡¢½¨Òé¡¢Ô¤²âµÈ£»£¨ 5 £©ÆäËü£º²»ÊôÓÚÑо¿¡¢ÑÐÖÆ¡¢µ÷²éµÄÖ÷ҪĿµÄ , µ«¾ßÓÐÖØÒªµÄÐÅÏ¢¼ÛÖµ¡£
    Ò»°ãµØËµ , ±¨µÀÐÔÕªÒªÖУ¨ 2 £©¡¢£¨ 3 £©¡¢£¨ 4 £©Ó¦Ïà¶ÔÏêϸ , £¨ 1 £©ºÍ£¨ 5 £©ÔòÏà¶Ô¼òÂÔ¡£Ö¸Ê¾ÐÔÕªÒªÔòÏà·´¡£
    ½á¹¹Ê½ÕªÒªÓ봫ͳһ¶ÎʽժҪµÄÇø±ðÔÚÓÚ£¬Æä·ÖÏî¾ßÌå , ¿Éʹ¶ÁÕ߸ü·½±ã¡¢¿ìËÙµØÁ˽âÂÛÎĵĸ÷ÏîÄÚÈÝ¡£Í³¼Æ±íÃ÷ , MEDLINE ¼ìË÷ϵͳËùÊÕ¼µÄÉúÎïҽѧÆÚ¿¯Ä¿Ç°ÒÑÓÐ 60% ÒÔÉϲÉÓÃÁ˽ṹʽժҪ¡£ÎÒ¹úÓÐЩҽѧÀàÆÚ¿¯ÔÚ 20 ÊÀ¼Í 90 Äê´ú³õ¿ªÊ¼²ÉÓýṹʽժҪ , ²¢¶ÔÆäʹÓÃЧ¹ûºÍ½øÒ»²½ÓÅ»¯½øÐÐÁ˽ÏΪÉîÈëµÄ̽ÌÖ¡£
    ½á¹¹Ê½ÕªÒªµÄ¹¹¼Ü¼°¼òҪ˵Ã÷    (1) Ä¿µÄ (Objective) £ºÑо¿µÄÎÊÌ⡢ĿµÄ»òÉèÏëµÈ£» ( 2) Éè¼Æ (Design) £ºÑо¿µÄ»ù±¾Éè¼Æ , Ñù±¾µÄÑ¡Ôñ¡¢·Ö×é¡¢Õï¶Ï±ê×¼ºÍËæ·ÃÇé¿öµÈ£» (3) µ¥Î» (Setting) £ºËµÃ÷¿ªÕ¹Ñо¿µÄµ¥Î»£¨ÊÇÑо¿»ú¹¹¡¢´óרԺУ , »¹ÊÇÒ½ÁÆ»ú¹¹£©£» (4) ¶ÔÏó (Patients,  Participants) £ºÑо¿¶ÔÏ󣨻¼Õߵȣ©µÄÊýÄ¿¡¢Ñ¡Ôñ¹ý³ÌºÍÌõ¼þµÈ£» (5) ´¦Öà (Interventions) £º´¦Ö÷½·¨µÄ»ù±¾ÌØÕ÷ , ʹÓúÎÖÖ·½·¨ÒÔ¼°³ÖÐøµÄʱ¼äµÈ£» ( 6) Ö÷Òª½á¹û²â¶¨ (Main Outcome Measures) £ºÖ÷Òª½á¹ûÊÇÈçºÎ²â¶¨¡¢Íê³ÉµÄ£»   (7) ½á¹û (Results) £ºÑо¿µÄÖ÷Òª·¢ÏÖ£¨Ó¦¸ø³öÈ·ÇеÄÖÃÐŶȺÍͳ¼ÆÑ§ÏÔÖøÐÔ¼ìÑéÖµ£©£» (8) ½áÂÛ (Conclusions) £ºÖ÷Òª½áÂÛ¼°ÆäDZÔÚµÄÁÙ´²Ó¦Óá£
    ʵ¼ÊÉÏ , 8 ¸ö²ã´Î±È½ÏÊʺÏÓÚÁÙ´²Ò½Ñ§ÀàԭʼÂÛÎÄ (Original Article) ¡£¶ÔÓÚ×ÛÊöÀàÂÛÎÄ , Æä½á¹¹Ê½ÕªÒªÓ¦°üÀ¨ÒÔÏ 6 ¸ö·½Ã棺 (1) Ä¿µÄ (Objective), (2) ×ÊÁÏÀ´Ô´ (Data Sources), (3) ×ÊÁÏÑ¡Ôñ (Study Selection), (4) Êý¾ÝÌáÁ¶ (Data Extraction), (5) ×ÊÁÏ×ÛºÏ (Data Synthesis), (6) ½áÂÛ (Conclusions) ¡£
    Ϊ½Úʡƪ·ù , ÓÐЩÆÚ¿¯ÔÚʹÓÃÖжÔÉÏÊö½á¹¹Ê½ÕªÒª½øÐÐÁËÊʵ±¼ò»¯ , Èç ¡°New England Journal of Medicine¡± ²ÉÓñ³¾° (Background) ¡¢·½·¨ (Methods) ¡¢½á¹û (Results) ¡¢½áÂÛ (Conclusions) µÈ 4 ¸ö·½Ã棻 ¡°The Lancet¡± Ôò²ÉÓñ³¾° (Background) ¡¢·½·¨ (Methods) ¡¢·¢ÏÖ (Findings) ºÍ½âÊÍ (Interpretation) µÈ 4 ¸ö·½Ãæ¡£
   JAMA (The Journal of the American Medical Association) ÊDzÉÓýṹʽժҪȫ²¿ÏîÄ¿µÄΪÊý²»¶àµÄÆÚ¿¯Ö®Ò» , ÆäԭʼÐÔÂÛÎĵÄÕªÒªÐë°üÀ¨ 9 Ïî (Context,  Objective,  Design,  Setting,  Patients,  Interventions,  Main Outcome Measures,  Results,  Conclusion), µ«×÷Õ߿ɸù¾ÝÐèÒª½«Ïà¹ØÏîÄ¿ºÏ²¢¡£
Ó봫ͳժҪ±È½Ï , ½á¹¹Ê½ÕªÒªµÄ³¤´¦ÊÇÒ×ÓÚд×÷£¨×÷Õ߿ɰ´²ã´ÎÌîÈëÄÚÈÝ£©ºÍ·½±ãÔĶÁ£¨Âß¼­×ÔÈ»¡¢ÄÚÈÝÍ»³ö£©£¬±í´ïÒ²¸üΪ׼ȷ¡¢¾ßÌå¡¢ÍêÕû¡£
    Ó¦¸Ã˵ , ÎÞÂÛÊÇ´«Í³µÄÒ»¶ÎʽժҪ , »¹ÊǽṹʽժҪ , ʵ¼ÊÉ϶¼Êǰ´Âß¼­´ÎÐò·¢Õ¹¶øÀ´ , ûÓÐÍÑÀë IMRAD µÄ·¶³ë .

2   ÕªÒª×«Ð´¼¼ÇÉ

2.1 ժҪ׫дµÄÒ»°ã¼¼ÇÉ   

    Ϊȷ±£ÕªÒªµÄ ¡° ¶ÀÁ¢ÐÔ ¡±(stand on its own) »ò ¡° ×ÔÃ÷ÐÔ ¡±(self-contained), ׫дÖÐÓ¦×ñÑ­ÒÔϹæÔò£º£¨ 1 £©ÎªÈ·±£¼ò½à¶ø³ä·ÖµØ±íÊöÂÛÎÄµÄ IMRD, ¿ÉÊʵ±Ç¿µ÷Ñо¿ÖеĴ´Ð¡¢ÖØÒªÖ®´¦ ( µ«²»ÒªÊ¹ÓÃÆÀ¼ÛÐÔÓïÑÔ ) £»¾¡Á¿°üÀ¨ÂÛÎÄÖеÄÖ÷ÒªÂÛµãºÍÖØÒªÏ¸½Ú£¨ÖØÒªµÄÂÛÖ¤»òÊý¾Ý£©¡££¨ 2 £©Ê¹Óüò¶ÌµÄ¾ä×Ó , ±í´ïҪ׼ȷ¡¢¼ò½à¡¢Çå³þ£»×¢Òâ±íÊöµÄÂß¼­ÐÔ , ¾¡Á¿Ê¹ÓÃָʾÐÔ´ÊÓï±í´ïÂÛÎĵIJ»Í¬²¿·Ö£¨²ã´Î£©¡£ ÈçʹÓà ¡°We found that¡­¡± ±íʾ½á¹û£¬Ê¹Óà ¡°We suggest that¡­¡± ±íʾÌÖÂÛ½á¹ûµÄº¬ÒåµÈ¡££¨ 3 £©Ó¦¾¡Á¿±ÜÃâÒýÓÃÎÄÏס¢Í¼±í , ÓôÊӦΪ¶ÁÕßËùÊìϤ¡£ÈôÎÞ·¨»Ø±ÜʹÓÃÒýÎÄ , Ó¦ÔÚÒýÎijöÏÖµÄλÖý«ÒýÎĵÄÊéÄ¿ÐÅÏ¢±ê×¢ÔÚ·½À¨ºÅÄÚ£»ÈçÈ·ÓÐÐèÒª£¨Èç±ÜÃâ¶à´ÎÖØ¸´½Ï³¤µÄÊõÓʹÓ÷ÇͬÐÐÊìÖªµÄËõд , Ó¦ÔÚËõд·ûºÅµÚÒ»´Î³öÏÖʱ¸ø³öÆäÈ«³Æ¡££¨ 4 £©Îª·½±ã¼ìË÷ϵͳת¼ , Ó¦¾¡Á¿±ÜÃâʹÓû¯Ñ§½á¹¹Ê½¡¢Êýѧ±í´ïʽ¡¢½Ç±êºÍÏ£À°ÎĵÈÌØÊâ·ûºÅ¡££¨ 5 £©²éѯÄâͶ¸åÆÚ¿¯µÄ¶ÁÕßÐëÖª , ÒÔÁ˽âÆä¶ÔÕªÒªµÄ×ÖÊýºÍÐÎʽµÄÒªÇó¡£Èç¹ûÊǽṹʽժҪ , Ó¦Á˽âÆä·ÖΪ¼¸¶Î£¬Ê¹ÓúÎÖÖ±êʶ£¬Ê¹ÓúÎÖÖʱ̬£¬ÊÇ·ñʹÓÃËõд»ò¼òд£¬µÈ¡£
    2.2 ժҪд×÷µÄʱ̬

   ÕªÒªËù²ÉÓõÄʱ̬ӦÒòÇé¿ö¶ø¶¨ , Á¦Çó±í´ï×ÔÈ»¡¢Í×µ±¡£Ð´×÷ÖпɴóÖÂ×ñÑ­ÒÔÏÂÔ­Ôò¡£
    2.2.1 ½éÉܱ³¾°×ÊÁÏ

   Èç¹û¾ä×ÓµÄÄÚÈÝÊDz»ÊÜʱ¼äÓ°ÏìµÄÆÕ±éÊÂʵ , ӦʹÓÃÏÖÔÚʽ£»Èç¹û¾ä×ÓµÄÄÚÈÝÊǶÔijÖÖÑо¿Ç÷ÊÆµÄ¸ÅÊö , ÔòʹÓÃÏÖÔÚÍê³Éʽ¡£ È磺
      The authors review risk and protective factors for drug abuse, assess a number of approaches for drug abuse prevention potential with high-risk groups,  and make recommendations for research and practice.
      Previous research has confirmed four dimensions of temperament: ¡­.   

    2.2.2   ÐðÊöÑо¿Ä¿µÄ»òÖ÷ÒªÑо¿»î¶¯

    Èç²ÉÓà ¡° ÂÛÎĵ¼Ïò ¡±, ¶àʹÓÃÏÖÔÚʽ£¨È磺 This paper presents¡­ £© ; Èç²ÉÓà ¡° Ñо¿µ¼Ïò ¡±, ÔòʹÓùýȥʽ£¨È磺 This study investigated¡­ £© .
      This article summarizes research on self-initiated and professionally facilitated change of addictive behaviors using the key transtheoretical constructs of stages and processes of change.   

We investigated whether captopril could reduce morbidity and mortality in patients with left ventricular dysfunction after a myocardial infarction.   

    2.2.3 ¸ÅÊöʵÑé³ÌÐò¡¢·½·¨ºÍÖ÷Òª½á¹û ͨ³£ÓÃÏÖÔÚʽ¡£
      We describe a new molecular approach to analyzing the genetic diversity of complex microbial populations.   

Our results indicate that p21 may be a universal inhibitor of cyclin kinases.
    2.2.4   ÐðÊö½áÂÛ»ò½¨Òé

    ¿ÉʹÓÃÏÖÔÚʽ¡¢Òܲ⶯´Ê»ò may,  should,  could µÈÖú¶¯´Ê¡£
      We suggest that climate instability in the early part of the last interglacial may have delayed the melting of the Saalean ice sheets in America and Eurasia , perhaps accounting for this discrepancy.   

  2.2   ÕªÒªÐ´×÷µÄÈ˳ƺÍÓï̬   

    ÓÐÏ൱ÊýÁ¿µÄ×÷ÕߺÍÉó¸åÈËÈÏΪ , ¿Æ¼¼ÂÛÎĵÄ׫дӦʹÓõÚÈýÈ˳ơ¢¹ýȥʱºÍ±»¶¯Óï̬¡£µ«µ÷²é±íÃ÷ , ¿Æ¼¼ÂÛÎÄÖб»¶¯Óï̬µÄʹÓÃÔÚ 1920 - 1970 ÄêÔø±È½ÏÁ÷ÐÐ , µ«ÓÉÓÚÖ÷¶¯Óï̬µÄ±í´ï¸üΪ׼ȷ , ÇÒ¸üÒ×ÔĶÁ , Òò¶øÄ¿Ç°´ó¶àÊýÆÚ¿¯¶¼ÌᳫʹÓÃÖ÷¶¯Ì¬¡£¹ú¼ÊÖªÃû¿Æ¼¼ÆÚ¿¯ ¡°Nature¡±,  ¡°Cell¡± µÈÓÈÆäÈç´Ë , ÆäÖеÚÒ»È˳ƺÍÖ÷¶¯Óï̬µÄʹÓÃÊ®·ÖÆÕ±é¡£
    ΪÁ˽âרҵÆÚ¿¯¶Ôд×÷·ç¸ñµÄ¹æ¶¨ , ÓÐÈËËæ»ú³é²éÁË 500 ·ÝҽѧºÍÉúÎïѧӢÎÄÆÚ¿¯µÄ ¡° ¶ÁÕßÐëÖª ¡± ¡£Í³¼Æ±íÃ÷ , 82% µÄÆÚ¿¯Ã»ÓÐÎÄ·ç·½ÃæµÄ¹æ¶¨¡£

¿É¼û , Ϊ¼ò½à¡¢Çå³þµØ±í´ïÑо¿³É¹û , ÔÚÂÛÎÄÕªÒªµÄ׫дÖв»Ó¦¿ÌÒâ»Ø±ÜµÚÒ»È˳ƺÍÖ÷¶¯Óï̬¡£

3   ÕªÒªµÄ³£Óñí´ï·½·¨
    ÓÉÓÚÕªÒªµÄÓ¢Îıí´ïÒªÇóÓôʼòÃ÷¡¢²ã´ÎÇå³þ , Òò´ËÕÆÎÕÒ»Ð©ÌØ¶¨µÄ¹æ·¶±í´ï , ÉõÖÁ½¨Á¢Ò»¸öÊʺÏ×Ô¼ºÐèÒªµÄ ¡° ¾äÐͿ⠡±(stock phrases), ¶ÔÓÚÕªÒªµÄ׫дÊǺÜÓаïÖúµÄ¡£±¾ÎÄËùѡȡµÄÀý¾ä¾ùÔ´ÓÚ SCI ÊÕ¼µÄ 1992 - 2002 Äê¼ä·¢±í¡¢²¢¾ß½Ï¸ß±»ÒýƵ´ÎµÄÂÛÎÄ£¨Ç° 100 λ£©ÕªÒª£¨Ñ¡È¡Àý¾äÊ±Æ«ÖØÓÚµÚÒ»È˳ƺÍÖ÷¶¯Óï̬£©¡£
    3.1   ÒýÑÔ²¿·Ö
    3.1.1 »Ø¹ËÑо¿±³¾° ³£ÓôʻãÓУº review,  summarize, present, outline, describe µÈ¡£ È磺 We review evidence for this view of addiction and discuss its implications for understanding the psychology and neurobiology of addiction.
      This paper outlines some of the basic methods and strategies and discusses some related theoretical and practical issues.

   3.1.2   ²ûÃ÷д×÷»òÑо¿Ä¿ ³£ÓôʻãÓУº purpose,  attempt,  aim µÈ¡£ÁíÍ⻹¿ÉÒÔÓö¯´Ê²»¶¨Ê½³äµ±Ä¿µÄ×´ÓïÀ´±í´ï¡£È磺
      We attempt to recover a function of unknown smoothness from noisy sampled data.   

To investigate the mechanism of Bcl-2's effect, we examined whether Bcl-2 interacted with other proteins.   

    3.1.3   ½éÉÜÂÛÎĵÄÖØµãÄÚÈÝ»òÑо¿·¶Î§ ³£ÓõĴʻãÓУº study,  present,  include,  focus,  emphasize,  emphasis,  attention µÈ¡£
      Here we study the dependence of apoptosis on p53 expression in cells from the thymus cortex.   

This article includes a brief review of the physics underlying HERWIG, followed by a description of the program itself.   

3.2   ·½·¨²¿·Ö
    3.2.1 ½éÉÜÑо¿»òÊÔÑé¹ý³Ì    ³£ÓôʻãÓУº test, study, investigate, examine, experiment, discuss, consider, analyze, analysis µÈ¡£
      We use N-body simulations to investigate the structure of dark halos in the standard cold dark matter cosmogony.

We present an analysis of atmospheric neutrino data from a 33. 0 kton yr (535-day) exposure of the Super-Kamiokande detector.   

  3.2.2 ˵Ã÷Ñо¿»òÊÔÑé·½·¨ ³£ÓôʻãÓУº measure,  estimate,  calculate µÈ¡£
      We have developed a global model to estimate emissions of volatile organic compounds from natural sources (NVOC).

This study presents estimates of lifetime and 12-month prevalence of 14 DSM-III-R psychiatric disorders from the National Comorbidity Survey, ¡­
     3.2.3   ½éÉÜÓ¦Óá¢ÓÃ; ³£ÓôʻãÓУº use,  apply,  application µÈ¡£
      Our program uses a maximum likelihood approach and is based on version 3. 3 of Felsenstein's dnaml program.

    As an application,  we implement a compact image coding algorithm that selects important edges and compresses the image data by factors over 30.   

3.3   ½á¹û²¿·Ö
     3.3.1   Õ¹Ê¾Ñо¿½á¹û ³£ÓôʻãÓУº show,  result,  present µÈ¡£
      We show this cell death to be dependent upon expression of c-myc protein and to occur by apoptosis.
        Our results suggest a widespread role for the nitric oxide-cyclic guanosine monophosphate system in the nervous system.

  3.3.2 ½éÉܽáÂÛ ³£ÓôʻãÓУº summary,  introduce,  conclude µÈ¡£
      We introduce a procedure,  SureShrink,  that suppresses noise by thresholding the empirical wavelet coefficients.

By means of informal mathematical arguments,  simulations and a series of worked examples,  we conclude that PQL is of practical value for approximate inference on parameters and realizations of random effects in the hierarchical model.

3.4   ÌÖÂÛ²¿·Ö
    3.4.1 ³ÂÊöÂÛÎĵÄÂÛµãºÍ×÷ÕߵĹ۵㠳£ÓôʻãÓУº suggest,  report,  present,  explain,  expect,  describe µÈ¡£
      The results suggest that abnormalities in male sex development induced by p, p'-DDE and related environmental chemicals may be mediated at the level of the androgen receptor.
      In this study, we describe a psychobiological model of the structure and development of personality that accounts for dimensions of both temperament and character.
    3.4.2 ²ûÃ÷ÂÛÖ¤ ³£ÓôʻãÓУº support, provide, indicate, identify, find, demonstrate, confirm, clarify µÈ¡£
      We showed that it is possible to identify constituents which represent only 1% of the total population.   

These results demonstrate that p53 is required for radiation-induced cell death in the thymus but is not necessary for all forms of apoptosis.   

3.4.3 ÍÆ¼öºÍ½¨Òé ³£ÓôʻãÓУº suggest, suggestion, recommend, recommendation, propose, necessity, necessary, expect µÈ¡£
      The authors suggest that the most promising route to effective strategies for the prevention of adolescent alcohol and other drug problems is through a risk-focused approach.
      We propose two algorithms to estimate the significance level for a test of HWP.

4   ½áÂÛ
    ÂÛÎÄÕªÒªµÄ׫дӦ³ä·Ö¿¼ÂÇÂÛÎĵÄÖ÷ÒªÄÚÈÝ , ¹ÊӦʹÓüò½àµÄÎÄ×Ö½«ÂÛÎĵľ«»ª¸ß¶ÈµØ¸ÅÀ¨³öÀ´¡£ÕªÒªµÄÄÚÈÝÓ¦´óÖ°üÀ¨ IMRAD ½á¹¹µÄÂÛÎÄд×÷ģʽ .
    д×÷ʱҪ¾¡Á¿Ê¹ÓõÚÒ»È˳ƺÍÖ÷¶¯Óï̬ , ¶Ôʱ̬µÄÑ¡ÔñÓ¦¸ù¾Ý±í´ïµÄÐèÒªÁé»îÔËÓá£
    ´ËÍâ , »¹Ó¦¸ù¾ÝÂÛÎĵÄÄÚÈݺͱí´ïµÄÐèҪѡÔñºÏÊʵÄÕªÒªÀàÐÍ£¨±¨µÀÐÔÕªÒª¡¢Ö¸Ê¾ÐÔÕªÒª¡¢±¨µÀ - ָʾÐÔÕªÒª£© , ÊÇ·ñ²ÉÓýṹʽժҪÐèÊÓÏàÓ¦ÆÚ¿¯µÄÒªÇó¶ø¶¨¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wrf3874

ÖÁ×ðľ³æ (ÕýʽдÊÖ)

1

Ì«ºÃÁË£¬ÕýºÃÐèÒª£¡
2Â¥2009-10-23 07:55:00
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lihongbo9079 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +22 ÄãºÃÃ÷ÌìÄãºÃ 2026-04-07 24/1200 2026-04-11 11:14 by ChemPharm
[¿¼ÑÐ] 290Çóµ÷¼Á +8 luoziheng 2026-04-10 8/400 2026-04-11 10:48 by qingpingzhu
[¿¼ÑÐ] ²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á +30 @ASDF1234 2026-04-08 32/1600 2026-04-11 10:30 by Delta2012
[¿¼ÑÐ] Ò»Ö¾Ô¸985»úеѧ˶380Çóµ÷¼Á +5 ¹Ø¹ØöÂð¯10 2026-04-11 5/250 2026-04-11 10:10 by ÖªÄî¡£A
[¿¼ÑÐ] 346£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶ +7 moser233 2026-04-10 8/400 2026-04-11 08:52 by Öí»á·É
[¿¼ÑÐ] 263ÄÜÔ´¶¯Á¦×¨Ë¶Çóµ÷¼Á +4 ¼Ó´óºÅ·¹ºÐ´ü 2026-04-10 4/200 2026-04-10 20:52 by gong120082
[¿¼ÑÐ] Çóµ÷¼Á +16 MAXâê㯠2026-04-09 18/900 2026-04-10 20:24 by С¹íม«¡«
[¿¼ÑÐ] Ò»Ö¾Ô¸¿ó´ó£¬²ÄÁϹ¤³Ìר˶314·Ö£¬0856¿Éµ÷¶¼¿ÉÒÔ +15 ÎÞи¿É»÷µÄ¾ÞÈË 2026-04-09 15/750 2026-04-10 18:10 by hmn_wj
[˶²©¼ÒÔ°] 0856²ÄÁÏ»¯¹¤Çóµ÷¼Á£¬Ò»Ö¾Ô¸211£¬³õÊԳɼ¨349 +5 ½­»´±±Ô 2026-04-05 5/250 2026-04-10 16:26 by ¸ßά´º
[¿¼ÑÐ] 314Çóµ÷¼Á +23 wakeluofu 2026-04-09 24/1200 2026-04-10 15:31 by MOF_Catal
[¿¼ÑÐ] Ò»Ö¾Ô¸Öпƴó070300»¯Ñ§£¬314·ÖÇóµ÷¼Á +12 wakeluofu 2026-04-09 12/600 2026-04-10 09:57 by liuhuiying09
[¿¼ÑÐ] 277Çóµ÷¼Á +19 Äß½¨Éè 2026-04-06 19/950 2026-04-10 09:24 by guosr9609
[¿¼ÑÐ] Çó»úеר˶297µÚ¶þÅúµ÷¼Á +5 ʰÆâ12¡£ 2026-04-08 5/250 2026-04-09 16:43 by Ôʵ±ÊʶÈ
[¿¼ÑÐ] »úе¹¤³Ì313·ÖÕÒ¹¤¿Æµ÷¼Á +3 ˫һÁ÷±¾¿Æ»úе 2026-04-08 3/150 2026-04-08 20:41 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö +23 haaaabcd 2026-04-05 26/1300 2026-04-08 16:19 by luoyongfeng
[¿¼ÑÐ] 326·Ö£¬Ò»Ö¾Ô¸»¦9£¬ÇóÉúÎïѧµ÷¼Á +4 Áõīī 2026-04-05 4/200 2026-04-08 06:22 by lijunpoly
[¿¼ÑÐ] ¼ÆËã»ú11408 287 Çóµ÷¼Á +3 LiLe5 2026-04-07 3/150 2026-04-07 23:15 by shanqishi
[¿¼ÑÐ] ÉúÎïѧ363µ÷¼ÁÇóÖú +7 fanzhang6666 2026-04-06 9/450 2026-04-07 17:37 by lijunpoly
[¿¼ÑÐ] ÉúÎ﹤³ÌÇóµ÷¼Á +13 ϲ»¶»¹ÊDz»¸ÊÐÄ 2026-04-05 13/650 2026-04-07 16:55 by Ecowxq666£¡
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +8 ÏàÐűػá¹ââÍòÕ 2026-04-05 10/500 2026-04-05 12:19 by Hdyxbekcb
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û